BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11259415)

  • 1. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression.
    Kito K; Yeh ET; Kamitani T
    J Biol Chem; 2001 Jun; 276(23):20603-9. PubMed ID: 11259415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1.
    Kamitani T; Kito K; Fukuda-Kamitani T; Yeh ET
    J Biol Chem; 2001 Dec; 276(49):46655-60. PubMed ID: 11585840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L.
    Tanaka T; Kawashima H; Yeh ET; Kamitani T
    J Biol Chem; 2003 Aug; 278(35):32905-13. PubMed ID: 12816948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD8 ultimate buster-1 regulates the abundance of TRF1 at telomeres by promoting its proteasomal degradation.
    Jeong YY; Her J; Chung IK
    FEBS Lett; 2016 Jun; 590(12):1776-90. PubMed ID: 27214791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis.
    Tanaka T; Yeh ET; Kamitani T
    Eur J Biochem; 2004 Mar; 271(5):972-82. PubMed ID: 15009209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation.
    Hipp MS; Raasi S; Groettrup M; Schmidtke G
    J Biol Chem; 2004 Apr; 279(16):16503-10. PubMed ID: 14757770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of NUB1 with the proteasome subunit S5a.
    Tanji K; Tanaka T; Kamitani T
    Biochem Biophys Res Commun; 2005 Nov; 337(1):116-20. PubMed ID: 16171779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.
    Bonacci T; Audebert S; Camoin L; Baudelet E; Iovanna JL; Soubeyran P
    PLoS One; 2017; 12(1):e0169988. PubMed ID: 28099510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel isopeptidase with dual specificity for ubiquitin- and NEDD8-conjugated proteins.
    Gong L; Kamitani T; Millas S; Yeh ET
    J Biol Chem; 2000 May; 275(19):14212-6. PubMed ID: 10799498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein.
    Kamitani T; Kito K; Nguyen HP; Yeh ET
    J Biol Chem; 1997 Nov; 272(45):28557-62. PubMed ID: 9353319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activating enzyme of NEDD8 inhibits steroid receptor function.
    Fan M; Long X; Bailey JA; Reed CA; Osborne E; Gize EA; Kirk EA; Bigsby RM; Nephew KP
    Mol Endocrinol; 2002 Feb; 16(2):315-30. PubMed ID: 11818503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.
    Liu G; Xirodimas DP
    Oncogene; 2010 Apr; 29(15):2252-61. PubMed ID: 20101219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
    Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T
    Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUB1, an interferon-inducible protein, mediates anti-proliferative actions and apoptosis in renal cell carcinoma cells through cell-cycle regulation.
    Hosono T; Tanaka T; Tanji K; Nakatani T; Kamitani T
    Br J Cancer; 2010 Mar; 102(5):873-82. PubMed ID: 20160729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach.
    Tan KL; Pezzella F
    Oncol Lett; 2016 Dec; 12(6):4287-4296. PubMed ID: 28101194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inherited blindness associated protein AIPL1 interacts with the cell cycle regulator protein NUB1.
    Akey DT; Zhu X; Dyer M; Li A; Sorensen A; Blackshaw S; Fukuda-Kamitani T; Daiger SP; Craft CM; Kamitani T; Sohocki MM
    Hum Mol Genet; 2002 Oct; 11(22):2723-33. PubMed ID: 12374762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.
    Lu B; Al-Ramahi I; Valencia A; Wang Q; Berenshteyn F; Yang H; Gallego-Flores T; Ichcho S; Lacoste A; Hild M; Difiglia M; Botas J; Palacino J
    Nat Neurosci; 2013 May; 16(5):562-70. PubMed ID: 23525043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of NEDD8 conjugation pathway by novel molecules and agents for anticancer therapy.
    Tanaka T; Nakatani T; Kamitani T
    Curr Pharm Des; 2013; 19(22):4131-9. PubMed ID: 23181574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction with Nedd8, a ubiquitin-like protein, enhances the transcriptional activity of the aryl hydrocarbon receptor.
    Antenos M; Casper RF; Brown TJ
    J Biol Chem; 2002 Nov; 277(46):44028-34. PubMed ID: 12215427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of NEDD8-conjugation site in human cullin-2.
    Wada H; Yeh ET; Kamitani T
    Biochem Biophys Res Commun; 1999 Apr; 257(1):100-5. PubMed ID: 10092517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.